1. Home
  2. ACHV vs CCG Comparison

ACHV vs CCG Comparison

Compare ACHV & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.65

Market Cap

167.6M

Sector

Health Care

ML Signal

HOLD

CCG

Cheche Group Inc.

N/A

Current Price

$0.98

Market Cap

81.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACHV
CCG
Founded
N/A
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
81.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
CCG
Price
$4.65
$0.98
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$15.50
$350.00
AVG Volume (30 Days)
590.2K
78.1K
Earning Date
11-06-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$444,290,042.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$0.71
52 Week High
$5.78
$1.54

Technical Indicators

Market Signals
Indicator
ACHV
CCG
Relative Strength Index (RSI) 52.73 45.21
Support Level $4.57 $0.93
Resistance Level $4.97 $1.00
Average True Range (ATR) 0.31 0.05
MACD -0.01 0.00
Stochastic Oscillator 57.31 41.67

Price Performance

Historical Comparison
ACHV
CCG

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

Share on Social Networks: